Abstract Objectives The Infectious Diseases Society of America and the American Society of
Clinical Oncology recommend risk stratification of patients with febrile neutropenia (FN) and …

Abstract Purpose The Multinational Association for Supportive Care in Cancer (MASCC)
score is used to risk stratify outpatients with febrile neutropenia (FN). However, it is rarely …

The success of modern anticancer treatment is a composite function of enhanced efficacy of
surgical, radiation and systemic treatment strategies and of our collective clinical abilities in …

Objectives The incidence of febrile neutropenia (FN) in acute leukemia patients following
induction or consolidation chemotherapy is high. Several clinical practice guidelines …

Background Dysphagia is a major symptom of esophageal cancer (EC) that significantly
affects patient quality of life; however, little is known regarding its clinical impact on the …

Previous studies have documented use of health care services by oncology patients in the
Emergency Department (ED), but little is known about the utilization of health services of …

Applying the principles of evidence-based medicine to febrile neutropenia (FN) results in a
more limited set of practices than expected. Hundreds of studies over the last 4 decades …

Since the start of the human immunodeficiency virus (HIV) epidemic, tumor disease among
patients has been significant. The collection of malignancies can be divided primarily into 2 …

Introduction Early toxic death (≤ 60 days of diagnosis) in elderly multiple myeloma (MM)
patients is attributable to active disease, age and co-morbidities. Rate of early toxic deaths is …

Cisplatin plus 5‐fluorouracil is regarded as standard neoadjuvant chemotherapy for
esophageal squamous cell carcinoma (ESCC) in Japan, but the prognosis remains poor …